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Background: Diabetic retinopathy (DR) is one of the leading causes for complete loss of vision among working-aged
adults around the world. The present study aims to evaluate the rate of DR and its risk factors among the adults with
young-onset diabetes from a tertiary care setting in Sri Lanka.
Methods: A consecutive sample of 1,007 individuals referred from multiple centers, were invited for the study.
Ophthalmological evaluation was done, with dilated indirect ophthalmoscopy by an Ophthalmologist. Retinopathy was
classified according to the International Clinical DR Disease Severity Scale. An interviewer-administered questionnaire
was used to collect socio-demographic and anthropometric details. Seated blood pressure, Fasting Blood Glucose (FBG),
HbA1c and urine microalbumin were also measured. Data were analysed using SPSSv14. A binary logistic regression
analysis was performed in all patients, with ‘presence of DR’ as the dichotomous dependent variable and other
independent covariates.
Results: Sample size was 684 (response rate–67.9%), mean age was 37.1 ± 5.9 years and 36.0% were males. Mean
duration of diabetes was 5.2 ± 4.0 years. Previous retinal screening had been done in 51.0% by a non-specialist doctor
and in 41.5% by a consultant ophthalmologist. Rate of any degree of DR in the study population was 18.1% (Males
16.4%, Females 20.0%; P = NS). In patients with DR, majority had mild Non-Proliferative DR (NPDR) (57.2%), while 32.2%
had moderate NPDR, 0.8% had severe NPDR and 9.7% had maculopathy. Mean age, duration of diabetes, systolic (SBP)
and diastolic blood pressure (DBP), FBG, HbA1c and urine microalbumin levels were significantly higher amongst the
patients with DR. The results of the binary logistic regression indicate that the duration of diabetes (OR:1.24), HbA1c
(OR:1.19), age (OR:1.11), urine Microalbumin (OR:1.11) and DBP (OR:1.04) all were significantly associated with DR.
Conclusions: In this large multi center study, nearly one in five adults with young-onset diabetes was found to have
retinopathy. Age, duration of diabetes, HbA1C and urine Microalbumin levels were significantly associated with the
presence of retinopathy, while HbA1c was also a significant factor determining severity. Nearly 50% of the study
population has never undergone retinal screening by an ophthalmologist, highlighting the need for well organized
screening programs.
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Diabetic retinopathy (DR) is the most common micro-
vascular complication of diabetes, resulting from retinal
vascular damage due to poor glycaemic control [1,2]. It
is one of the leading causes for complete loss of vision
among working-aged adults around the world [3]. DR is
the cause of blindness in approximately 2.5 million of the
estimated 50 million blind people in the world [4]. Loss of
productivity and reduced quality of life for the patient
with DR leads to additional socio-economic burdens on
the community. In patients with type 2 diabetes 50-70%
have been observed to have DR after 10 years, and 90%
after 30 years [5,6]. The prevalence of DR is significantly
higher in type 1 than in type 2 diabetics and it is also more
aggressive and accelerated in patients with type 1 diabetes
[7]. Retinopathy in diabetes is known to be associated with
the duration of diabetes, sub-optimal glycaemic control,
presence of hypertension and diabetic nephropathy [8-10].
South Asia, commonly known as the Indian sub-con
tinent, is home to almost one-quarter of the world’s popula-
tion. Currently South Asia is experiencing a significant epi-
demic of diabetes with a rapid increase in prevalence over
the last two decades [11]. There is conflicting evidence re-
garding the epidemiology of DR in South Asians. The U.K.
Prospective Diabetes Study (UKPDS) showed a similar
prevalence of retinopathy in South Asian, Afro-Caribbean,
and white Europeans with diabetes [12]. However, several
subsequent studies in UK reported a higher prevalence of
retinopathy in South Asians residing in UK than in the na-
tive European population [13,14]. Genetic differences be-
tween racial groups may contribute to this differential
occurrence of DR in the different ethnic groups.
The prevalence of diabetes mellitus has reached epi-
demic proportions in Sri Lanka. In 2005, the prevalence
was nearly 11%, while 1/5th of the adult population were
suffering from dysglysaemia (diabetes and pre-diabetes),
furthermore it is estimated that over 1/3rd of the popula-
tion may be undiagnosed [15,16]. In 1993, Fernando et al.
studied 1,003 Sri Lankan patients with type 2 diabetes at-
tending a clinic and demonstrated that 31.3% had DR and
23% had cataract [17]. Weerasuriya et al., conducted a
study among newly diagnosed patients with type 2 diabetes
residing in the Colombo district of Sri Lanka in 1998 and
showed a 15% prevalence of DR [18]. However, there
are no recent large scale multi-center studies evaluating
the prevalence of DR and its associations in Sri Lankan
adults with young-onset diabetes. The present study aims
to evaluate the rate of DR and its risk factors among the
young adult patients with diabetes from Sri Lanka.
Methods
Study population and sampling
In this study, a consecutive sample of 1,007 individuals
was referred from; 1) the three largest government tertiarycare hospitals in Colombo (National Hospital of Sri Lanka,
Colombo South Teaching Hospital and Colombo North
Teaching Hospital), 2) diabetes and medical outpatient
clinics of few other selected government hospitals, 3) re-
ferrals from physicians or general practitioners and 4) the
National Diabetes Centre in Sri Lanka. At these centers
the total number of diabetic patient visits are more than
10,000/month. All young-adults, who had been diag-
nosed with diabetes between 16–40 years of age and
who were ≤45 years at the time of the study were re-
ferred. Patients with history of glaucoma, dense cataract
and corneal opacities were excluded, as it was difficult
to perform retinal screening. In addition pregnant women
were also not included in the study. Those providing in-
formed written consent was recruited for the study. Re-
cruitment was carried out during a period of 9 months,
from June 2005 to February 2006. The study was con-
ducted in accordance with the principles of the Declaration
of Helsinki. Ethics approval for the study was obtained
from the Ethics Review Committee, Faculty of Medicine,
University of Colombo.
Ophthalmological examination
Ophthalmological evaluation was done at the National
Eye Hospital, Colombo, Sri Lanka, which is the largest
tertiary care eye hospital in the country. All patients had
their pupils dilated with 1% tropicamide and was examined
for DR by an Ophthalmologist by indirect ophthalmoscopy
using slit lamp biomicroscopy. Features identified in slit
lamp examination was recorded and retinopathy was clas-
sified in to the following categories, according to the Inter-
national Clinical DR Disease Severity Scale; normal, mild
Non Proliferative DR (NPDR), moderate NPDR, severe
NPDR, proliferative DR and clinically significant macular
edema (maculopathy) (Additional file 1) [19]. The presence
of retinopathy in one eye was considered a diagnosis of DR
and when asymmetrical DR was present the stage of retin-
opathy was based on the affected eye with the more severe
grade of DR.
Data collection and definitions
Data collection was carried out at the Diabetic Research
Unit, Department of Clinical Medicine, Faculty of Medi-
cine, University of Colombo. An interviewer administered
questionnaire was used to collect socio-demographic and
anthropometric details including age, gender, duration of
diabetes, height, weight, waist circumference and hip
circumference. Height was measured using Harpenden
stadiometers (Chasmors Ltd, London, UK) to the nearest
0.1 cm, according to standard methods. Body weight
was measured using a SALTER 920 digital weighing
scale (SALTER Ltd, Tonbridge, UK) to the nearest 0.1 kg.
Body Mass Index (BMI) was calculated as weight in kilo-
grams divided by height squared in meters (kg/m2). Waist
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iliac crest and the lower rib margin at the end of normal
expiration and hip circumference was measured at the
widest level over the greater trochanters using a plastic
flexible tape to the nearest 0.1 cm. Waist to Hip Ratio
(WHR) and Waist to Height Ratio (WHtR) were calcu-
lated as waist circumference divided by hip circumference
and height respectively.
Seated blood pressure was measured after at least a
10-min rest with Omron IA2 digital blood pressure moni-
tors (Omron Healthcare, Singapore). The following bio-
chemical tests were also done; Fasting Blood Glucose (FBG)
(glucose oxidase method – Hitachi 704 chemical auto-
analyzer), Glycosylated haemoglobin (HPLC technique) and
urine microalbumin. Hypertension was defined as systolic
blood pressure > 130 mmHg and/or diastolic blood pres-
sure > 80 mmHg and/or being on anti-hypertensive treat-
ment. Central obesity was classified as WC> 90 cm for
males and > 80 cm for females (Asian cut-offs) [20]. Obesity
was defined as a BMI ≥ 27.5 kg/m2, based on WHO criteria
for Asians [21].
Statistical analysis
Data were analysed using SPSS v14 (SPSS Inc., Chicago,
IL, USA) statistical software package. The significance of
the differences between proportions and means was tested
using z-test and Student’s t-test or ANOVA respectively.
Subjects were divided in to two groups based on the pres-
ence or absence of DR. A binary logistic regression ana-
lysis was performed in all patients with ‘presence of DR’
as the dichotomous dependent variable (0 = DR absent;
1 = DR present) and age, duration of diabetes, BMI, WC,
hip circumference, systolic blood pressure, diastolic blood
pressure, FBG, HbA1c and urine microalbumin as the
continuous independent variables. The explanatory inde-
pendent variables that were associated with the dependent
variable in univariate analysis (p < 0.25) were selected to
be included in the regression analysis. The explanatory
variables selected above were subsequently included in a
binary logistic regression model, a backward elimination
procedure was used and a p-value of 0.10 was considered
as the cutoff for removal of variables. A similar binary lo-
gistic regression analysis with above dependant and inde-
pendent variables was also performed separately for both
males and females.
To evaluate factors associated with the severity of DR,
patients with DR were regrouped in to the following two
groups; 1) ‘mild’ disease (patients with mild NPDR) and
2) ‘moderate-severe’ disease (patients with moderate NPDR,
severe NPDR and maculopathy). A binary logistic regres-
sion analysis was performed in all patients with DR, using
‘moderate-severe DR’ as the dichotomous dependent vari-
able (0=’mild’ DR; 1=’moderate-severe DR) and duration of
diabetes, systolic blood pressure, diastolic blood pressure,HbA1c and urine Microalbumin as the continuous inde-
pendent variables. The explanatory independent variables
were selected as in the above regression analysis. In all stat-
istical analyses p < 0.05 was considered significant.Results
Sample characteristics
A sample of 1,007 individuals were referred from the above
centre’s and 684 consented to participate in the study (re-
sponse rate – 67.9%), mean age (±SD) was 37.1 ± 5.9 years
and 36.0% (n = 246) were males. The mean age of diabetes
diagnosis (±SD) and duration of diabetes (±SD) were
31.9 ± 5.7 years and 5.2 ± 4.0 years (range 1–24 years)
respectively. The prevalence of obesity (BMI ≥ 27.5 kg/m2)
and central obesity (based on waist circumference) in
the study population were 18.9% (n = 129) and 62.9%
(n = 430) respectively. Hypertension was present in 23.1%
(n = 158) of the study population. In the current study
population the mean FBG was 166.5 ± 68.6 mg/dl, and the
mean HbA1c was 8.1 ± 2.0% (65.0 mmol/mol). Out of all
the patients in the study, previous retinal screening had
been not been done in 34.1% (n = 233), and in the 65.9%
who underwent previous examination it was done by only
a consultant ophthalmologist in 12.7% (n = 87), by only a
non-specialist doctor in 26.4% (n = 180) and by both in
26.8% (n = 183).Rate, clinical and biochemical correlates of DR
The rate of any degree of DR in the study population was
18.1% (n = 124). There was no significant gender differ-
ence observed in the rate of DR (Males 16.4%, Females
20.0%; P =NS). The rate of cataract was 5.1% (Males 3.4%,
Females 6.1%; P =NS). In the patients with DR, majority
had mild NPDR (57.2%, n = 71), while 32.2% (n = 40) had
moderate NPDR, 0.8% (n = 1) had severe NPDR and 9.7%
(n = 12) had maculopathy. There were no patients with
PDR in the current study population. The mean age, dur-
ation of diabetes, systolic and diastolic blood pressure,
fasting blood glucose, HbA1c and urine microalbumin
levels were significantly higher amongst the patients with
DR than those without (Table 1). However the mean
weight, BMI, waist and hip circumferences were signifi-
cantly lower in the patients with DR (Table 1). The dur-
ation of diabetes, HbA1c, systolic and diastolic blood
pressures were significantly higher in patients with macu-
lopathy than in patients with mild NPDR (Table 1).
In all adults the rate of DR was significantly higher in
patients who were having; a duration of diabetes > 5 years,
systolic hypertension or diastolic hypertension or both, a
HbA1c of > 6.5% (> 47.5 mmol/mol) and a urine Microal-
bumin of > 200 mg/l (Table 2). However the rate of DR
was significantly lower in patients who were obese. A simi-
lar pattern was observed independently in females, but in




Absent Present Mild NPDR Moderate NPDR Maculopathy
Mean (±SD) Mean (±SD) Mean (±SD) Mean (±SD) Mean (±SD)
Age (years) 36.5 (±5.9) 39.8 (±4.6) <0.001 39.1 (±5.1) 40.4 (±4.0) 40.8 (±3.0)
Duration of diabetes (years) 4.4 (±3.3) 8.5 (±4.9) <0.001 7.9 (±4.7)♯ 8.8 (±4.9)§ 11.2 (±5.0)♯,§
Height (cm) 157.6 (±10.0) 156.2 (±8.0) NS 155.9 (±8.0) 156.0 (±7.4) 158.4 (±10.4)
Weight (kg) 61.9 (±11.9) 57.1 (±9.6) <0.001 57.2 (±10.2) 55.8 (±9.0) 60.4 (±8.7)
Body Mass Index (kg/m2) 24.8 (±4.2) 23.3 (±3.2) <0.001 23.4 (±3.2) 22.8 (±3.4) 24.1 (±2.7)
Waist circumference (cm) 87.4 (±9.8) 85.0 (±8.4) <0.05 84.8 (±8.6) 84.3 (±8.3) 88.7 (±5.9)
Hip circumference (cm) 96.0 (±15.5) 91.8 (±6.3) <0.01 92.2 (±6.5) 90.6 (±6.1) 93.5 (±5.1)
Waist to hip ratio 0.91 (±0.06) 0.92 (±0.06) NS 0.92 (±0.05) 0.93 (±0.06) 0.95 (±0.04)
Waist to height ratio 0.56 (±0.07) 0.54 (±0.05) NS 0.54 (±0.05) 0.54 (±0.06) 0.56 (±0.04)
Systolic blood pressure (mmHg) 119.1 (±12.7) 124.2 (±17.1) <0.001 121.3 (±16.3)♯ 125.3 (±16.1) 138.1 (±19.4)♯
Diastolic blood pressure (mmHg) 74.8 (±8.9) 77.4 (±10.2) <0.01 75.9 (±8.9)♯ 77.9 (±11.7) 83.4 (±10.6)♯
Fasting blood glucose (mg/dl) 163.6 (±66.8) 184.2 (±76.5) <0.01 180.6 (±73.5) 187.4 (±82.0) 201.9 (±76.2)
HbA1c (%) [mmol/mol] 7.9% (±2.0) [62.8] 9.0% (±1.8) [74.9] <0.001 8.7 (±1.8)♯ [71.6] 9.4 (±1.6) [79.2] 10.1 (±1.2)♯ [86.9]
Urine Microalbumin (mg/l)¥ 7.9 (3.6 – 26.5) 14.3 (4.2 – 53.2) <0.05 9.8 (4.1 – 45.6)♯ 23.3 (7.2 – 71.2)♯ 11.5 (3.0 – 97.5)
*- patients with and without diabetes retinopathy; NPDR – Non Proliferative Diabetic Retinopathy; NS – Not Significant; ¥- Median and inter-quartile range;
♯,§values in a single row with the same superscript in the diabetes retinopathy grade are significantly different from each other (p < 0.01).
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not significantly influence the rate of DR (Table 2).
Results of the logistic regression analysis
The results of the binary logistic regression analysis in
all adults using the dichotomous variable ‘presence of
DR’ as the dependant factor and other independent vari-
ables are shown in Table 3. The overall model was statis-
tically significant and the Cox & Snell R-Square and
Nagelkerke R Square values were 0.232 and 0.384 re-
spectively. The results indicate that the duration of dia-
betes (OR: 1.24), HbA1c (OR: 1.19), age (OR: 1.11), urine
Microalbumin (OR: 1.11) and diastolic blood pressure
(OR: 1.04) all were associated with significantly increased
risk of developing DR (Table 3). Duration of diabetes,
HbA1c and urine Microalbumin were also associated with
developing DR in both males and females independently
(Table 3). However age, systolic and diastolic blood pres-
sure did not show a consistent relationship when both
genders were considered separately. In the regression ana-
lysis evaluating factors associated with the severity of DR,
only HbA1c (OR: 1.38) and systolic blood pressure (OR:
1.03) were significantly associated with the presence of
‘moderate-severe DR’.
Discussion
To our knowledge this is the largest study from the
South Asian region among adult patients with young-
onset diabetes. In this cohort of patients there was a
higher proportional prevalence of type 2 diabetes (nearly
95%), while autoimmune diabetes was much less commonthan in the European populations [22]. Type 2 diabetes
occurs at a younger age in South Asians when compared
to Europeans [23]. Due to their longer exposure to hyper-
glycemia, patients with young‐onset type 2 diabetes are at
an increased risk of developing diabetes related complica-
tions. In addition there is considerable evidence to support
the fact that complications are commoner amongst South
Asian patients with diabetes [24]. The decline in glycaemic
control over time is also much more rapid among South
Asians [25]. Hence, diabetes among South Asians repre-
sents a differential disease with a much more aggressive
progression than in other ethnic groups. A significant ma-
jority of studies evaluating complication and risk factors
in young-adult South Asians with diabetes are amongst
the South Asian immigrant populations living in devel-
oped countries. Changes in lifestyles associated with mi-
gration could play a role in the pathogenesis of diabetes
and its complications in these migrant South Asians living
in western developed countries. Hence, the current study
is important as we look at the rate and risk factors for
developing DR a common complication of diabetes, in a
large cohort of ethnic South Asian adults with young-
onset diabetes residing in South Asia. In addition, from
a public health perspective adults with young-onset dia-
betes represents a group of patients in whom early risk
factor interventions may significantly attenuate the risk
of complications.
In the current cohort the rate of DR was 18.7% (Males
16.4%, Females 20.0%), with a majority of patients having
either mild (57.2%) or moderate (32.2%) NPDR. A similar
prevalence was observed among South Asians residing in
Table 2 Rate of retinopathy in association with anthropometric, clinical and biochemical parameters
Rate of diabetic retinopathy (%, [95% CI])
All adults Males Females
Duration of diabetes
≤ 5 years 9.4 (6.7 – 12.6)§ 5.7 (2.6 – 10.6)§ 11.5 (7.9 – 16.1)§
> 5 years 34.7 (28.8 – 41.0)§ 37.0 (26.6 – 48.5)§ 33.5 (26.4 – 41.3)§
Central obesity*
Absent 19.7 (15.0 – 25.0) 16.8 (11.1 – 23.9) 23.8 (15.9 – 33.3)
Present 18.2 (14.7 – 22.1) 15.8 (9.1 – 24.7) 18.9 (14.8 – 23.6)
Obesity (BMI > 27.5 kg/m2)
Absent 21.2 (17.8 – 24.9)§ 17.8 (12.8 – 23.8)§ 23.2 (18.8 – 28.2)§
Present 8.9 (4.5 – 15.3)§ 6.3 (1.0 – 10.8)§ 9.8 (4.6 – 17.8)§
Systolic hypertension (> 130 mmHg)
Absent 16.3 (13.2 – 19.7)§ 14.9 (10.1 – 21.0) 17.0 (13.2 – 21.4)§
Present 28.7 (21.1 – 37.3)§ 20.4 (10.6 – 33.6) 34.7 (24.0 – 46.5)§
Diastolic hypertension (> 80 mmHg)
Absent 17.4 (14.4 – 20.7)§ 15.5 (10.8 – 21.3) 18.4 (14.6 – 22.7)§
Present 27.6 (21.5 – 36.2)§ 20.0 (8.4 – 36.9) 32.7 (24.3 – 43.1)§
Hypertension♯
Absent 16.6 (13.5 – 20.2)§ 15.5 (10.4 – 21.8) 17.2 (13.3 – 21.7)§
Present 25.3 (21.7 – 30.8)§ 17.9 (9.6 – 29.2) 30.8 (24.6 – 37.3)§
HbA1c
≤ 6.5% (≤ 47.5 mmol/mol) 7.1 (3.7 – 12.0)§ 1.7 (0.04 – 8.9)§ 10.0 (5.1 – 17.2)§
> 6.5% (> 47.5 mmol/mol) 22.7 (19.0 – 26.7)§ 21.7 (15.8 – 28.6)§ 23.2 (18.6 – 28.3)§
Urine microalbumin
< 20 mg/l 14.7 (11.1 – 18.9)§ 8.8 (4.5 – 15.2)§ 18.0 (13.2 – 23.7)§
20 – 200 mg/l 22.0 (15.6 – 29.5) 26.5 (16.5 – 38.6) 18.3 (10.6 – 28.4)
> 200 mg/l 41.2 (25.4 – 60.1)§ 33.3 (17.5 – 50.1)§ 50.0 (25.7 – 74.3)§
§Values under each variable in a single column with the same superscript are significantly different from each other (p < 0.01); ♯systolic hypertension or diastolic
hypertension or both; *waist circumference > 90 cm for males and > 80 cm for females.
Katulanda et al. BMC Endocrine Disorders 2014, 14:20 Page 5 of 8
http://www.biomedcentral.com/1472-6823/14/20UK (17.6%), while this prevalence was significantly higher
than the native Europeans (7.9%) with young-onset type 2
diabetes [13]. However, our rate was higher than the rate
observed in similar studies among young adults with
diabetes from India (5.3%), Malaysia (10.0%) and China
(15.1%) [26]. Although nearly one in five Sri Lankan
adults with young-onset diabetes was found to have DRTable 3 Binary logistic regression analysis on presence of ret
Co-variants All adults
Age (years) 1.11 (1.04 – 1.18)#
Duration of diabetes (years) 1.24 (1.15 – 1.33)*
Systolic blood pressure (mm Hg) NA
Diastolic blood pressure (mm Hg) 1.04 (1.01 – 1.07)§
HbA1c (%) 1.19 (1.04 – 1.36)#
Urine Microalbumin (mg/l) 1.11 (1.10 – 1.21)§
*- p < 0.001, #- p < 0.01, §- p <0.05; NA – Not Associated.(after a mean duration of 5 years from diagnosis), a sig-
nificant majority (89.4%) are having only mild degrees
of DR. This rapid onset of DR in young patient with type
2 diabetes emphasizes the importance of careful and regu-
lar ophthalmological evaluation in all patients from the
time of diagnosis. Furthermore the high rate of mild DR is
important since appropriate measures instituted at theseinopathy in all adults, males and females
Odds ratio (95% CI)
Male Female
NA 1.11 (1.02 – 1.21)§
1.56 (1.32 – 1.82)* 1.19 (1.10 – 1.29)*
NA 1.02 (1.00 – 1.05)§
NA NA
1.32 (1.05 – 1.64)§ 1.20 (1.10 – 1.30)#
1.10 (1.05 – 1.15)§ 1.16 (1.10 – 1.22)§
Katulanda et al. BMC Endocrine Disorders 2014, 14:20 Page 6 of 8
http://www.biomedcentral.com/1472-6823/14/20early stages can either halt or slowdown the progression
of disease. However, in the present study previous retinal
screening has been done only in 40.7% by a specialist oph-
thalmologist and 51.1% by a medical officer. These find-
ings highlights the need for well organized systematic
screening programs for DR. Effective screening and treat-
ment programs are known to reduce the burden of blind-
ness due to diabetes, especially in vulnerable populations
[27]. However, in limited resource settings such as in Sri
Lanka with low access to specialist care, a suitable alterna-
tive could be to train primary care clinicians to recognize
DR in at risk populations with a reasonable degree of ac-
curacy [28].
In the Sri Lankan adult population with young-onset
diabetes age, duration of diabetes, HbA1C and urine
Microalbumin levels were significantly associated with the
presence of DR, while HbA1c was also a significant pre-
dictor of severity. In addition, HbA1c had a stronger asso-
ciation with the occurrence of DR than FBG (Table 1).
HbA1c has been described as a predictor of both micro-
and macrovascular complications of diabetes and studies
have shown a linear increase in the prevalence of DR
when HbA1c is more than 6.5% (47.5 mmol/mol) [29].
This highlights the importance of regular HbA1c meas-
urement and the need for targeted ophthalmological as-
sessment in patients with higher HbA1c values. However,
recent studies have shown that costlier laboratory investi-
gations like HbA1c and urine Microalbumin are fre-
quently missed benchmarks in diabetes care in Sri Lanka,
as facilities are currently unavailable in the Government
Health Sector [30]. Considering the finding that age, dur-
ation of diabetes and HbA1c all were significantly associ-
ated with DR, it can be concluded that long term poor
glycaemic control is responsible for the observed increase
in risk. However, it is important to appreciate that poor
glycaemic control is a risk factor that is amenable to inter-
vention. We also observed that patients with DR had a
significantly higher degree of microalbuminuria and the
degree of microalbuminuria was higher in those moderate
DR than in those with mild DR. Studies have shown that
irrespective of the age of onset, individuals with microal-
buminuria are more likely to have retinopathy than those
without microalbuminuria, even after controlling for po-
tential confounders such as glycaemic control, hyperten-
sion and duration of diabetes [31]. In addition patients
with microalbuminuria and DR have shown a more rapid
decline in renal function in prospective follow up studies
[32]. Therefore targeted screening for DR is recommended
for all patients with microalbuminuria, so that treatment
can be instituted in the required patients to prevent ocular
morbidity/blindness [33].
We also observed a negative relationship between an-
thropometric measurements (weight, BMI, WC and hip
circumference) and the presence of DR. This relationshiphas similarly been examined in numerous epidemiologic
studies, but results have been inconsistent. The Diabetes
Control and Complications Trial (DCCT) reported that
high BMI was associated with DR [34]. The EURODIAB
Study reported that the WHR was an independent risk
factor for DR after ≥ 7 years of follow-up [35]. In contrast,
Chaturvedi and Fuller, Dowse et al. and Lim, et al. re-
ported that decreasing BMI is associated with a higher
prevalence of DR [5,36,37]. Our results are in conformity
with these latter studies. Leanness is probably an indicator
of the severity of diabetes and long standing exposure to
hyperglycemia. Another possible explanation is that per-
sons with DR could have adopted positive behavioral
modifications after diagnosis that has led to healthy an-
thropometric parameters.
There are several limitations to our study, the cross-
sectional design of our study can only demonstrates an
association between DR and identified risk factors, and
limits the inference of causality. Therefore, it is important
to conduct prospective studies in newly diagnosed young-
onset adult patients with diabetes without DR and look for
causality during subsequent follow up. The lack of fundus
photographs is also a limitation; it is possible that we may
have missed patients with early DR, resulting in the under-
estimation of rate. Retinal photography is the gold standard
for the diagnosis of DR. In addition the grading given by
the ophthalmologist was not validated by measuring intra/
inter-observer concordance. However, ophthalmoscopy by
experienced ophthalmologists also has been shown to have
acceptable sensitivity and is useful in resource limited set-
tings such as in Sri Lanka [38]. We were also unable to
evaluate data on treatment, including insulin therapy and
its’ association with DR. We recruited the present sample
from patients referred from three large tertiary care hospi-
tals in Sri Lanka, located in the most urban parts of the
country, which could have led to a significant selection
bias. Furthermore it is important to appreciate that clinic
based data as in the context of the current study, over esti-
mates the actual community prevalence and disease bur-
den. Hence there is a need for population based studies
evaluating complications in adult patients with young-
onset diabetes.
Conclusions
In this large multi center study nearly one in five adults
with young-onset diabetes was found to have retinopathy,
with a majority having only mild degrees of retinopathy.
Age, duration of diabetes, HbA1C and urine Microalbu-
min levels were significantly associated with the presence
of retinopathy, while HbA1c was also a significant factor
determining severity. Nearly 50% of the study population
has never undergone retinal screening by an ophthalmolo-
gist, highlighting the need for well organized screening
programs. In addition there is also an urgent need for
Katulanda et al. BMC Endocrine Disorders 2014, 14:20 Page 7 of 8
http://www.biomedcentral.com/1472-6823/14/20population based studies evaluating the true disease bur-
den related to retinopathy in Sri Lankan adult patients
with young-onset diabetes.
Additional file
Additional file 1: Diabetic retinopathy disease severity scale.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
PK, MJ, NPW, RS and DRM made substantial contribution to conception and
study design. MJ, NPW and PK were involved in data collection. YCW, PR,
WMUAW, PK, RS and DRM were involved in refining the study design,
statistical analysis and drafting the manuscript. YCW, PR, WMUAW and PK
critically revised the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
The authors would like to thank the staff of the retinal unit, room number 1
and 2 of the Eye Hospital Colombo, the staff of the Diabetes Research Unit
of the Faculty of Medicine of the University of Colombo for their support
and all subjects who participated in the study.
Author details
1Department of Clinical Medicine, Faculty of Medicine, University of
Colombo, Kynsey Road, Colombo, Sri Lanka. 2Oxford Centre for Diabetes,
Endocrinology and Metabolism, University of Oxford, Oxford, United
Kingdom. 3Ministry of Health Care and Nutrition, Colombo, Sri Lanka.
4Department of Pharmacology, Faculty of Medicine, University of Colombo,
Colombo, Sri Lanka.
Received: 6 October 2013 Accepted: 26 February 2014
Published: 4 March 2014
References
1. Abbate M, Cravedi P, Iliev I, Remuzzi G, Ruggenenti P: Prevention and
treatment of diabetic retinopathy: evidence from clinical trials and
perspectives. Curr Diabetes Rev 2011, 7:190–200.
2. Fowler MJ: Microvascular and macrovascular complications of diabetes.
Clinical Diabetes 2008, 26:77–82.
3. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose
control with sulphonylureas or insulin compared with conventional
treatment and risk of complications in patients with type 2 diabetes
(UKPDS 33). Lancet 1998, 352:837–853.
4. Viswanath K, McGavin DD: Diabetic retinopathy: clinical findings and
management. Community Eye Health 2003, 16:21–24.
5. Dowse GK, Humphrey AR, Collins VR, Plehwe W, Gareeboo H, Fareed D,
Hemraj F, Taylor HR, Tuomilehto J, Alberti KG, Zimmet PZ: Prevalence and
risk factors for diabetic retinopathy in the multiethnic population of
Mauritius. Am J Epidemiol 1998, 147:448–457.
6. de Fine ON, Nielsen NV, Andreasen AH: Diabetic retinopathy in newly
diagnosed middle-aged and elderly diabetic patients. Prevalence and
interrelationship with microalbuminuria and triglycerides. Graefes Arch
Clin Exp Ophthalmol 2001, 239:664–672.
7. Dedov I, Maslova O, Suntsov Y, Bolotskaia L, Milenkaia T, Besmertnaia L:
Prevalence of diabetic retinopathy and cataract in adult patients with
type 1 and type 2 diabetes in Russia. Rev Diabet Stud 2009, 6:124–129.
8. Ben Hamouda H, Messaoud R, Grira S, Ayadi A, Khairallah M, Soua H, Sfar MT:
Prevalence and risk factors of diabetic retinopathy in children and young
adults. J Fr Ophtalmol 2001, 24:367–370.
9. Raymond NT, Varadhan L, Reynold DR, Bush K, Sankaranarayanan S, Bellary S,
Barnett AH, Kumar S, O’Hare JP, Group UKADSRS: Higher prevalence of
retinopathy in diabetic patients of South Asian ethnicity compared with
white Europeans in the community: a cross-sectional study. Diabetes Care
2009, 32:410–415.
10. Manaviat MR, Afkhami M, Shoja MR: Retinopathy and microalbuminuria in
type II diabetic patients. BMC Ophthalmol 2004, 4:9.11. Jayawardena R, Ranasinghe P, Byrne NM, Soares MJ, Katulanda P, Hills AP:
Prevalence and trends of the diabetes epidemic in South Asia: a
systematic review and meta-analysis. BMC Public Health 2012, 12:380.
12. Prospective UK, Diabetes Study Group: UK prospective diabetes study. XII:
differences between asian, afro-caribbean and white caucasian type 2
diabetic patients at diagnosis of diabetes. Diabet Med 1994, 11:670–677.
13. Chowdhury TA, Lasker SS: Complications and cardiovascular risk factors in
South Asians and Europeans with early-onset type 2 diabetes. QJM 2002,
95:241–246.
14. Pardhan S, Gilchrist J, Mahomed I: Impact of age and duration on
sight-threatening retinopathy in South Asians and Caucasians attending
a diabetic clinic. Eye (Lond) 2004, 18:233–240.
15. Katulanda P, Constantine GR, Mahesh JG, Sheriff R, Seneviratne RDA,
Wijeratne S, Wijesuriya M, McCarthy MI, Adler AI, Matthews DR: Prevalence and
projections of diabetes and pre-diabetes in adults in Sri Lanka - Sri Lanka
diabetes, cardiovascular study (SLDCS). Diabet Med 2008, 25:1062–1069.
16. Wijewardene K, Mohideen MR, Mendis S, Fernando DS, Kulathilaka T,
Weerasekara D, Uluwitta P: Prevalence of hypertension, diabetes and
obesity: baseline findings of a population based survey in four provinces
in Sri Lanka. Ceylon Med J 2005, 50:62–70.
17. Fernando DJ, Siribaddana S, De S, Subasinge Z: Prevalence of retinopathy
in a Sri Lankan diabetes clinic. Ceylon Med J 1993, 38:120–123.
18. Weerasuriya N, Siribaddana S, Dissanayake A, Subasinghe Z, Wariyapola D,
Fernando DJ: Long-term complications in newly diagnosed Sri Lankan
patients with type 2 diabetes mellitus. QJM 1998, 91:439–443.
19. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D,
Kampik A, Pararajasegaram R, Verdaguer JT, Global Diabetic Retinopathy
Project G: Proposed international clinical diabetic retinopathy and
diabetic macular edema disease severity scales. Ophthalmology 2003,
110:1677–1682.
20. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA,
Fruchart JC, James WP, Loria CM, Smith SC Jr, International Diabetes
Federation Task Force on Epidemiology and Prevention; Hational Heart,
Lung, and Blood Institute; American Heart Association; World Heart
Federation; International Atherosclerosis Society; International Association
for the Study of Obesity: Harmonizing the metabolic syndrome: a joint
interim statement of the International Diabetes Federation Task Force
on Epidemiology and Prevention; National Heart, Lung, and Blood
Institute; American Heart Association; World Heart Federation;
International Atherosclerosis Society; and International Association for
the Study of Obesity. Circulation 2009, 120:1640–1645.
21. WHO Expert Consultation: Appropriate body-mass index for Asian populations
and its implications for policy and intervention strategies. Lancet 2004,
363:157–163.
22. Katulanda P, Shine B, Katulanda GW, Silva A, Asfir EL, Sheriff R,
Somasundaram N, Long AE, Bingley PJ, McCarthy MI, Clark A, Matthews DR:
Diabetes mellitus among young adults in Sri Lanka–role of GAD
antibodies in classification and treatment: the Sri Lanka Young Diabetes
study. Diabetologia 2008, 51:1368–1374.
23. Mather HM, Keen H: The Southall diabetes survey: prevalence of known
diabetes in asians and europeans. Br Med J (Clin Res Ed) 1985, 291:1081–1084.
24. Mather HM, Chaturvedi N, Fuller JH: Mortality and morbidity from diabetes in
South Asians and Europeans: 11-year follow-up of the Southall diabetes
survey, London, UK. Diabet Med 1998, 15:53–59.
25. Mukhopadhyay B, Forouhi NG, Fisher BM, Kesson CM, Sattar N: A
comparison of glycaemic and metabolic control over time among South
Asian and European patients with Type 2 diabetes: results from follow-up
in a routine diabetes clinic. Diabet Med 2006, 23:94–98.
26. Rema M, Mohan V: Retinopathy at diagnosis among young Asian diabetic
patients: the ASDIAB study group. Diabetes 2002, 51:A206–A207.
27. Ferris FL 3rd: How effective are treatments for diabetic retinopathy? JAMA
1993, 269:1290–1291.
28. Farley TF, Mandava N, Prall FR, Carsky C: Accuracy of primary care
clinicians in screening for diabetic retinopathy using single-image retinal
photography. Ann Fam Med 2008, 6:428–434.
29. Expert Committee on the D, Classification of Diabetes M: Report of the
expert committee on the diagnosis and classification of diabetes
mellitus. Diabetes Care 2003, 26 Suppl 1:S5–S20.
30. Jayawardena MHDS, Idampitiya C, Jayawarna C, Wanigasuriya K, Thomson GA,
Fernando DJS: An audit of standards of care at a Sri Lankan diabetic clinic.
Diabetes Res Clin Pract 2007, 75:249–251.
Katulanda et al. BMC Endocrine Disorders 2014, 14:20 Page 8 of 8
http://www.biomedcentral.com/1472-6823/14/2031. Cruickshanks KJ, Ritter LL, Klein R, Moss SE: The association of
microalbuminuria with diabetic retinopathy. The Wisconsin epidemiologic
study of diabetic retinopathy. Ophthalmology 1993, 100:862–867.
32. Moriya T, Tanaka S, Kawasaki R, Ohashi Y, Akanuma Y, Yamada N, Sone H,
Yamashita H, Katayama S, Japan Diabetes Complications Study G: Diabetic
retinopathy and microalbuminuria can predict macroalbuminuria and
renal function decline in Japanese type 2 diabetic patients: Japan
diabetes complications study. Diabetes Care 2013, 36:2803–2809.
33. Reddy SC, Kihn YM, Nurjahan MI, Ramil A: Retinopathy in type 2 diabetic
patients with microalbuminuria. Nepal J Ophthalmol 2013, 5:69–74.
34. Zhang L, Krzentowski G, Albert A, Lefebvre PJ: Risk of developing
retinopathy in diabetes control and complications trial type 1 diabetic
patients with good or poor metabolic control. Diabetes Care 2001,
24:1275–1279.
35. Chaturvedi N, Sjoelie AK, Porta M, Aldington SJ, Fuller JH, Songini M, Kohner EM,
Study EPC: Markers of insulin resistance are strong risk factors for retinopathy
incidence in type 1 diabetes. Diabetes Care 2001, 24:284–289.
36. Chaturvedi N, Fuller JH: Mortality risk by body weight and weight change
in people with NIDDM. The WHO multinational study of vascular disease
in diabetes. Diabetes Care 1995, 18:766–774.
37. Lim LS, Tai ES, Mitchell P, Wang JJ, Tay WT, Lamoureux E, Wong TY:
C-reactive protein, body mass index, and diabetic retinopathy. Invest
Ophthalmol Vis Sci 2010, 51:4458–4463.
38. Garg S, Davis RM: Diabetic retinopathy screening update. Clin Diabetes
2009, 27:140–145.
doi:10.1186/1472-6823-14-20
Cite this article as: Katulanda et al.: Retinopathy among young adults
with Diabetes Mellitus from a tertiary care setting in Sri Lanka. BMC
Endocrine Disorders 2014 14:20.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
